世界の体外受精装置及び消耗品市場の規模、シェア、競争環境及び動向分析レポート- 製品別(器具、アクセサリー及び消耗品、試薬及びメディア)、技術別(新鮮胚体外受精、凍結胚体外受精、ドナー卵子体外受精)、エンドユーザー別(不妊治療診療所、病院、手術センター、臨床研究機関): 2024-2032年におけるまでの機会分析及び産業予測
レポートID : ROJP0424002 | 発行日 : 2024年04月 | フォーマット : : :
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global IVF Devices and Consumables Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Instruments
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Sperm Separation Systems
6.1.2.2 Cryosystems
6.1.2.3 Incubators
6.1.2.4 Imaging Systems
6.1.2.5 Ovum Aspiration Pumps
6.1.2.6 Cabinets
6.1.2.7 Micromanipulators
6.1.2.8 Others
6.1.3 Market Forecast
6.2 Accessories and Disposables
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Reagents and Media
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Cryopreservation Media
6.3.2.2 Semen Processing Media
6.3.2.3 Ovum Processing Media
6.3.2.4 Embryo Culture Media
6.3.3 Market Forecast
7 Market Breakup by Technology
7.1 Fresh Embryo IVF
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Frozen Embryo IVF
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Donor Egg IVF
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Fertility Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Surgical Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Clinical Research Institutes
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Coopersurgical Inc. (The Cooper Companies Inc)
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Esco Medical
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Genea Biomedx
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Hamilton Thorne Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 INVO Bioscience
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Memmert GmbH + Co.KG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Nidacon International AB
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Rocket Medical Plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Thermo Fisher Scientific
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Vitrolife
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio